Optimizing pain control through the use of implantable pumps

10Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Intrathecal therapy represents an effective and well established treatment of nonmalignant as well as malignant pain. Devices available include mechanical constant flow pumps as well as electronic variable flow pumps with patient-controlled bolus release. The latter provide faster dose finding, individual pain control, and good acceptance by patients. New technologies such as membrane pumps and rechargeable devices are expected to be developed to clinical perfection. The available drugs for intrathecal therapy are listed according to the polyanalgesic consensus on intrathecal therapy. The integration of remote patient-controlled analgesia into electronic implantable devices, and the peptide analgesic ziconotide, have signifi cantly improved intrathecal therapy. Complications include infections, catheter ruptures or disconnections, catheter granulomas, and technical dysfunctions. Further possibilities for optimizing intrathecal therapy include development of new drugs, drug side effects, catheter and pump technologies, and surgical techniques. © 2008 Dove Medical Press Limited. All rights reserved.

Cite

CITATION STYLE

APA

Ilias, W., & Todoroff, B. (2008). Optimizing pain control through the use of implantable pumps. Medical Devices: Evidence and Research. Dove Medical Press Ltd. https://doi.org/10.2147/mder.s3623

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free